Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

By Bosly A.  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 277-283

Springer Publishing Company

Access to resources Recommend Favorite

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

By Hirakawa Tsuneaki   Yamaguchi Hiroki   Yokose Norio   Gomi Seiji   Inokuchi Koiti   Dan Kazuo  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 897-904

Springer Publishing Company

Access to resources Recommend Favorite

Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (盧)CHOP

By Pettengell Ruth  

Hematology, Vol. 18, Iss. 1, 2013-01 ,pp. : 26-29

Maney Publishing

Access to resources Recommend Favorite

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

By Li J.   Wang L.   Shen Y.   Xia Z.   Chen Y.   Chen Q.   Chen Y.   Zeng X.   You J.   Qian Y.   Shen Z.  

Annals of Hematology, Vol. 86, Iss. 9, 2007-09 ,pp. : 639-645

Springer Publishing Company

Access to resources Recommend Favorite

Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country?

By Ruiz-Delgado Guillermo J   Gómez-Almaguer David   Tarín-Arzaga Luz C   Cantú-Rodriguez Olga G   Urdaneta Carlos Alarcón   Rodríguez-Morales Uxmal   Calderón-Garcia Jackeline   Fernández-Vargas Omar   Montes-Montiel Maryel   Sánchez-Cárdenas Mónica   Ruiz-Argüelles Guillermo J  

Hematology, Vol. 17, Iss. 4, 2012-07 ,pp. : 193-197

Maney Publishing

Access to resources Recommend Favorite